Linking diabetic cardiovascular disease with non-alcoholic fatty liver disease through L-carnitine: A hyperpolarized MRS study

Linking diabetic cardiovascular disease with non-alcoholic fatty liver disease through L-carnitine: A hyperpolarized MRS study

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Savic, D, Ball, V, Pavlides, M, Heather, LC, Tyler, DJ
Μορφή:	Conference item
Γλώσσα:	English
Έκδοση:	Elsevier 2019

Παρόμοια τεκμήρια

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
ανά: Savic, D, κ.ά.
Έκδοση: (2020)

L-Carnitine stimulates in vivo carbohydrate metabolism in the Type 1 diabetic heart as demonstrated by hyperpolarized MRI
ανά: Savic, D, κ.ά.
Έκδοση: (2021)

Simultaneous in vivo assessment of cardiac and hepatic metabolism in the diabetic rat using hyperpolarized MRS
ανά: Le Page, L, κ.ά.
Έκδοση: (2016)

Detection and alterations of acetylcarnitine (AC) in human liver by 1H MRS at 3T after supplementation with L-carnitine
ανά: Savic, D, κ.ά.
Έκδοση: (2022)

Non-alcoholic fatty liver disease
ανά: Pavlides, M, κ.ά.
Έκδοση: (2019)

Assessing the optimal preparation strategy to minimize the variability of cardiac pyruvate dehydrogenase flux measurements with hyperpolarized MRS
ανά: Timm, KN, κ.ά.
Έκδοση: (2018)

Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
ανά: Na Li, κ.ά.
Έκδοση: (2021-08-01)

Investigating the functional and metabolic role of carnitine in the diabetic heart using hyperpolarized MRI
ανά: Savic, D
Έκδοση: (2018)

L-Carnitine Stimulates In Vivo Carbohydrate Metabolism in the Type 1 Diabetic Heart as Demonstrated by Hyperpolarized MRI
ανά: Dragana Savic, κ.ά.
Έκδοση: (2021-03-01)

Clinical cardiovascular applications of hyperpolarized magnetic resonance
ανά: Lewis, AJM, κ.ά.
Έκδοση: (2020)

Fast Padé transform accelerated CSI for hyperpolarized MRS
ανά: Hansen, E, κ.ά.
Έκδοση: (2016)

Cardiovascular Applications of Hyperpolarized MRI.
ανά: Tyler, D
Έκδοση: (2011)

Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
ανά: Alexandra Jichitu, κ.ά.
Έκδοση: (2021-04-01)

Hyperpolarized 13 C and 31 P MRS detects differences in cardiac energetics, metabolism, and function in obesity, and responses following treatment
ανά: Lewis, AJM, κ.ά.
Έκδοση: (2024)

Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
ανά: Yohwan Lim, κ.ά.
Έκδοση: (2023-06-01)

The role of non-alcoholic fatty liver disease in the development of cardiovascular diseases
ανά: R. A Eganyan
Έκδοση: (2018-03-01)

In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate.
ανά: Hu, S, κ.ά.
Έκδοση: (2009)

Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease
ανά: Hak Soo Kim, κ.ά.
Έκδοση: (2017-06-01)

Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.
ανά: Schroeder, M, κ.ά.
Έκδοση: (2011)

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
ανά: Tae Hyun Kim, κ.ά.
Έκδοση: (2021-12-01)

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
ανά: Nicholas W.S. Chew, κ.ά.
Έκδοση: (2022-08-01)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
ανά: Rahul Sao, κ.ά.
Έκδοση: (2017-07-01)

Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting
ανά: Paula Luque-Linero, κ.ά.
Έκδοση: (2024-05-01)

Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease
ανά: Daciana Dascalu
Έκδοση: (2023-04-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
ανά: G. Yu. Knorring, κ.ά.
Έκδοση: (2024-08-01)

Non-alcoholic fatty liver disease and cardiovascular risks: A review
ανά: Yulia V. Kotovskaya
Έκδοση: (2023-07-01)

BIOMARKERS OF CARDIOVASCULAR RISK IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
ανά: Petrov I. M., κ.ά.
Έκδοση: (2020-06-01)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
ανά: Karthik Chandrasekharan, κ.ά.
Έκδοση: (2020-01-01)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
ανά: Bilon Khambu, κ.ά.
Έκδοση: (2018-09-01)

Research Progress in the Correlation of Non-alcoholic Fatty Liver Disease and Metabolic-associated Fatty Liver Disease with Cardiovascular Diseases in China and Abroad
ανά: NI Xuetong, WANG Ruoxi, ZHANG Jing, YANG Xinghua
Έκδοση: (2024-06-01)

The Role of Carnitine Orotate Complex in Fatty Liver
ανά: Hyon-Seung Yi
Έκδοση: (2021-11-01)

Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy
ανά: A. V. Nelidova, κ.ά.
Έκδοση: (2022-01-01)

Risk factors for cardiovascular disease in patients with non-alcoholic fatty liver disease with polymorbidity
ανά: E. V. Sevostyanova, κ.ά.
Έκδοση: (2019-11-01)

Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease
ανά: Beliz Bahar Karaoğlan, κ.ά.
Έκδοση: (2023-03-01)

Hyperpolarized butyrate: a metabolic probe of short chain fatty acid metabolism in the heart.
ανά: Ball, DR, κ.ά.
Έκδοση: (2014)

Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
ανά: Rosa Lombardi, κ.ά.
Έκδοση: (2021-02-01)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
ανά: Dongqing Wu, κ.ά.
Έκδοση: (2021-07-01)

Clinical translation of hyperpolarized magnetic resonance for cardiovascular and metabolic diseases
ανά: Lewis, A
Έκδοση: (2017)

Models to predict non-alcoholic fatty liver disease linked to obesity in Morocco
ανά: Habiba Liba, κ.ά.
Έκδοση: (2022-09-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE
ανά: O. M. Drapkina, κ.ά.
Έκδοση: (2017-11-01)